Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Wolf

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Journal of Bacteriology|July 16, 2013
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivityPatrik Engström, Bidong D Nguyen, Johan Normark, et al.
American Journal of Obstetrics and Gynecology|April 5, 2011
Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancyAleid G van Wassenaer, Jolanda Westera, Petra E M van Schie, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 3, 2019
Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted FetusesNicola Fratelli, Federico Prefumo, Hans Wolf, et al.
Annals of Hematology|April 13, 2006
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Olaf Penack, Thomas Beinert, Dieter Buchheidt, et al.
Vaccine|January 17, 2007
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade CCarmen Elena Gómez, Jose Luis Nájera, Victoria Jiménez, et al.
Mbio|January 1, 2015
A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatisPatrik Engström, K Syam Krishnan, Bidong D Ngyuen, et al.
Vaccine|May 10, 2008
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primatesBabs E Verstrepen, Adriaan D Bins, Christine S Rollier, et al.
Cell Host & Microbe|April 24, 2012
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunctionUlrich Meinzer, Frederick Barreau, Sophie Esmiol-Welterlin, et al.
Journal of Virology|January 11, 2008
Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primatesPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Gerrit Koopman, et al.
BMJ (Clinical Research Ed.)|March 7, 2009
Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort studyRoel de Heus, Ben Willem Mol, Jan-Jaap H M Erwich, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Journal of Bacteriology|July 16, 2013
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivityPatrik Engström, Bidong D Nguyen, Johan Normark, et al.
American Journal of Obstetrics and Gynecology|April 5, 2011
Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancyAleid G van Wassenaer, Jolanda Westera, Petra E M van Schie, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 3, 2019
Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted FetusesNicola Fratelli, Federico Prefumo, Hans Wolf, et al.
Annals of Hematology|April 13, 2006
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Olaf Penack, Thomas Beinert, Dieter Buchheidt, et al.
Vaccine|January 17, 2007
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade CCarmen Elena Gómez, Jose Luis Nájera, Victoria Jiménez, et al.
Mbio|January 1, 2015
A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatisPatrik Engström, K Syam Krishnan, Bidong D Ngyuen, et al.
Vaccine|May 10, 2008
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primatesBabs E Verstrepen, Adriaan D Bins, Christine S Rollier, et al.
Cell Host & Microbe|April 24, 2012
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunctionUlrich Meinzer, Frederick Barreau, Sophie Esmiol-Welterlin, et al.
Journal of Virology|January 11, 2008
Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primatesPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Gerrit Koopman, et al.
BMJ (Clinical Research Ed.)|March 7, 2009
Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort studyRoel de Heus, Ben Willem Mol, Jan-Jaap H M Erwich, et al.
Pageof 18